K. Osei

D. Schuster, K. Dungan, K. Osei, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Global epidemic of type 2 diabetes: implications for developing countries.

K. Osei, 2003, Ethnicity & disease.

James R. Gavin III, MD, PhD—A Humble and Remarkable Trailblazer, Scientist, Advocate, Mentor, and Educator for Diabetes

K. Osei, S. Golden, 2015, Diabetes Care.

Decreased Serum C-Peptide/Insulin Molar Ratios After Oral Glucose Ingestion in Hyperthyroid Patients

K. Osei, J. Falko, T. O'dorisio, 1984, Diabetes Care.

Differential impact of obesity on glucose metabolism in black and white American adolescents.

D. Schuster, K. Osei, C. L. Kien, 1998, The American journal of the medical sciences.

Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma.

K. Osei, J. Falko, K. Nelson, 1984, The American journal of medicine.

Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

D. Schuster, K. Osei, T. Gaillard, 2007, Metabolism: clinical and experimental.

Physiological and Pharmacological Stimulation of Pancreatic Islet Hormone Secretion in Type I Diabetic Pancreas Allograft Recipients

K. Osei, M. Henry, T. O'dorisio, 1990, Diabetes.

Post-transplantation hypoglycaemia in type 1 diabetic pancreas allograft recipients

K. Osei, 1998, Acta Diabetologica.

Sequential Metabolic Studies of Pancreas Allograft Function in Type 1 Diabetic Recipients

K. Osei, M. Henry, D. Cottrell, 1992, Diabetic medicine : a journal of the British Diabetic Association.

Long‐term Safety of Pioglitazone versus Glyburide in Patients with Recently Diagnosed Type 2 Diabetes Mellitus

Alfonso T. Perez, K. Osei, R. Jain, 2006, Pharmacotherapy.

Ethnic differences in glucose effectiveness and disposition index in overweight/obese African American and white women with prediabetes: A study of compensatory mechanisms.

K. Osei, T. Gaillard, 2017, Diabetes research and clinical practice.

Sandostatin®: Assay and Efficacy in VIPoma and Insulinoma

K. Osei, T. Gaginella, M. O'dorisio, 1989 .

Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

D. Schuster, K. Osei, T. Gaillard, 2004, Diabetes care.

Comparison of the Portal Vein and Kidney Subcapsule as Sites for Primate Islet Autotransplantation

K. Osei, A. Rajab, J. Buss, 2008, Cell transplantation.

Hypoglycemia After Successful Pancreas Transplantation in Type I Diabetic Patients

K. Osei, M. Henry, D. Cottrell, 1991, Diabetes Care.

The Use of Continuous Subcutaneous Octreotide Infusion in Brittle Type 1 Diabetic Patients

K. Osei, J. Falko, T. O'dorisio, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Ethnic Differences in Secretion, Sensitivity, and Hepatic Extraction of Insulin in Black and White Americans

D. Schuster, K. Osei, 1994, Diabetic medicine : a journal of the British Diabetic Association.

HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women

K. Osei, S. Parthasarathy, T. Gaillard, 2011, Diabetes Care.

Insulin insensitivity and glucose effectiveness in type I diabetic allograft pancreas recipients.

K. Osei, M. Henry, D. Cottrell, 1992, Transplantation proceedings.

Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM

K. Osei, D. Cottrell, M. M. Orabella, 1991, Diabetes Care.

Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM.

K. Osei, 1990, Diabetes.

Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring.

D. Schuster, K. Osei, 1996, American journal of hypertension.

Continuous subcutaneous octreotide infusion: dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (type 1) diabetes.

W. Malarkey, K. Osei, T. O'dorisio, 1991, The Journal of laboratory and clinical medicine.

Pregnancy complicated by insulinoma.

W. Malarkey, K. Osei, J. Falko, 1984, The American journal of the medical sciences.

Ambulatory and exercise-induced blood pressure responses in type I diabetic patients and normal subjects.

K. Osei, 1987, Diabetes research and clinical practice.

Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.

K. Osei, M. Henry, R. Ferguson, 1994, Transplantation proceedings.

Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

D. Schuster, K. Osei, A. Amoah, 2002, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects.

D. Schuster, K. Osei, A. Amoah, 2001, Ethnicity & disease.

Racial Disparities in the Pathogenesis of Type 2 Diabetes and its Subtypes in the African Diaspora: A New Paradigm

K. Osei, T. Gaillard, 2016, Journal of Racial and Ethnic Health Disparities.

Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness

D. Schuster, K. Osei, T. Gaillard, 1997, Diabetes Care.

Correction of aberrant NADPH oxidase activity in blood-derived mononuclear cells from type II diabetes mellitus patients by a naturally fermented papaya preparation.

G. Gordillo, D. Schuster, K. Osei, 2012, Antioxidants & redox signaling.

Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.

K. Osei, J. Falko, T. O'dorisio, 1986, The Journal of clinical endocrinology and metabolism.

Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort

N. Kressin, L. Tamariz, T. Craven, 2018, Diabetes, obesity & metabolism.

Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in Type 1 (insulin-dependent) diabetic pancreas allograft recipients

K. Osei, M. Henry, D. Cottrell, 1992, Diabetologia.

β-Cells with Relative Low HIMP1 Overexpression Levels in a Transgenic Mouse Line Enhance Basal Insulin Production and Hypoxia/Hypoglycemia Tolerance

K. Osei, Yun Cao, Jie Wang, 2012, PloS one.

Primary adrenal insufficiency manifesting as malignant lymphoma.

K. Osei, E. Pacht, J. Falko, 1983, Archives of internal medicine.

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.

Michael F Dulin, C. Lewis, W. Cushman, 2015, American journal of hypertension.

Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials

Mark A Espeland, Sharon Wilmoth, I. Hramiak, 2009, Clinical trials.

Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and White Americans With Prediabetes: Implications for the Metabolic Paradoxes

K. Osei, T. Gaillard, S. Healy, 2014, Diabetes Care.

Importance of Aerobic Fitness in Cardiovascular Risks in Sedentary Overweight and Obese African-American Women

W. M. Sherman, K. Osei, S. Devor, 2007, Nursing research.

Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome

K. Osei, T. Gaillard, 2017, Front. Endocrinol..

Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

D. Schuster, K. Osei, T. Gaillard, 2006, Ethnicity & disease.

Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria.

D. Schuster, K. Osei, T. Gaillard, 2009, Ethnicity & disease.

Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks

B. Egan, K. Ferdinand, E. Saunders, 2015, Journal of clinical hypertension.

Exercise-mediated changes in high-density lipoprotein: impact on form and function.

S. Rajagopalan, K. Osei, Jessica Rutsky, 2013, American heart journal.

Metabolic consequences of the West African diaspora: lessons from the thrifty gene.

K. Osei, Kwame Osei, 1999, The Journal of laboratory and clinical medicine.

The Impact of Socioeconomic Status on Cardiovascular Risk Factors in African-Americans at High Risk for Type II Diabetes: Implications for syndrome X

D. Schuster, K. Osei, T. Gaillard, 1997, Diabetes Care.

Facilities and resources for diabetes care at regional health facilities in southern Ghana.

K. Osei, A. Amoah, W. Fang, 1998, Diabetes research and clinical practice.

Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations.

D. Schuster, K. Osei, A. Amoah, 2003 .

Pathogenesis of Type 1 and Type 2 Diabetes Mellitus in Sub-Saharan Africa: Implications for Transitional Populations

D. Schuster, K. Osei, A. Amoah, 2003, Journal of cardiovascular risk.

Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

D. Schuster, K. Osei, A. Amoah, 2002, Ethnicity & disease.

Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial

S. Oparil, W. Cushman, W. Kostis, 2017, Journal of hypertension.

Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.

P. Binkley, K. Dungan, K. Osei, 2016, Journal of diabetes and its complications.

A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation

P. Binkley, K. Dungan, K. Osei, 2015, Diabetes/metabolism research and reviews.

Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.

D. Schuster, C. Wooley, D. Stakos, 2007, European journal of endocrinology.

Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study

D. Schuster, C. Wooley, D. Stakos, 2005, Heart.

Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.

D. Schuster, C. Wooley, D. Stakos, 2003, Journal of cardiology.

Do Sociodemographics and Economic Status Predict Risks for Type II Diabetes in African Americans?

D. Schuster, K. Osei, T. Gaillard, 1997, The Diabetes educator.

Insulin resistance and systemic hypertension.

K. Osei, 1999, The American journal of cardiology.

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes

P. Binkley, K. Dungan, K. Osei, 2015, Inflammation.

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes

P. Binkley, K. Dungan, K. Osei, 2015, Inflammation.

Substrate-Favored Lysosomal and Proteasomal Pathways Participate in the Normal Balance Control of Insulin Precursor Maturation and Disposal in β-Cells

K. Osei, Wei-Yu Tang, Q. Yuan, 2011, PloS one.

Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

D. Schuster, K. Osei, T. Gaillard, 2003, The Journal of clinical endocrinology and metabolism.

Minimal model analyses of insulin sensitivity and glucose‐dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes

K. Osei, D. Cottrell, 1994, European journal of clinical investigation.

Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus.

K. Osei, C. A. Adejuwon, K. Akinlade, 1993, Diabetes research and clinical practice.

Awareness of risk factors for type 2 diabetes in women with current and former gestational diabetes mellitus (GDM): Implications for future primary diabetes prevention

D. Schuster, K. Osei, M. Landon, 2010 .

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.

G. Umpierrez, Limin Peng, K. Dungan, 2017, The lancet. Diabetes & endocrinology.

Proinsulin Atypical Maturation and Disposal Induces Extensive Defects in Mouse Ins2+/Akita β-Cells

K. Osei, Wei-Yu Tang, J. Hinson, 2012, PloS one.

Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives.

H. Nagaraja, P. Binkley, D. Schuster, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Patient-Centered Community Diabetes Education Program Improves Glycemic Control in African-American Patients with Poorly Controlled Type 2 Diabetes: Importance of Point of Care Metabolic Measurements.

K. Osei, T. Gaillard, G. Amponsah, 2015, Journal of National Black Nurses' Association : JNBNA.

Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

D. Schuster, K. Osei, T. Gaillard, 2003, Metabolism: clinical and experimental.

Exenatide substantially improves proinsulin conversion and cell survival that augment Ins2 +/Akita beta cell function

K. Osei, Wei-Yu Tang, Q. Yuan, 2017, Molecular and Cellular Endocrinology.

Does oral supplementation of a fermented papaya preparation correct respiratory burst function of innate immune cells in type 2 diabetes mellitus patients?

G. Gordillo, K. Osei, Sashwati Roy, 2015, Antioxidants & redox signaling.

Control of Precursor Maturation and Disposal Is an Early Regulative Mechanism in the Normal Insulin Production of Pancreatic β-Cells

K. Osei, Jie Wang, Wei-Yu Tang, 2011, PloS one.

Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes

P. Binkley, K. Dungan, K. Osei, 2013, Diabetes, obesity & metabolism.